1er Centre Médical des Armées
Paris, 75012, France
NCT Number: NCT04893070
In April 2020, a meta-analysis on the long-term sequelae of respiratory syndromes related to seasonal coronaviruses (SARS and MERS) showed a significant alteration in quality of life, with in particular a decrease in physical and emotional capacities and a deterioration of social life. An improvement of the quality of life is evidenced after 6 months but without reaching the level usually observed in healthy people. The impact of SARS-CoV-2 infection on quality of life can be explained by the persistence of pleomorphic symptoms in the medium to long term. In the military population, the majority of SARS-CoV-2 cases present minor to moderate forms of the disease. Military personnel have living conditions that differ from those of the general population, in particular because of their geographic mobility, which may be responsible for isolation from the family. This isolation can be regular (we speak of "geographical celibacy" when the soldier is posted in a geographical area far from the family unit) and/or occasional, during missions on the national territory or outside. This singularity justifies a study on the impact of SARS-CoV-2 (COVID-19) infection on the quality of life in this specific population.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Paris, 75012, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 18 months after COVID-19 first symptoms
Mental Component Score (MCS) of the SF-36 questionnaire. The MCS ranges from 0 (bad quality of life) to 100 (good quality of life).
Time frame: 18 months after COVID-19 first symptoms
Physical Component Score (PCS) of the SF-36 questionnaire. The PCS ranges from 0 (bad quality of life) to 100 (good quality of life).
Direction Centrale du Service de Santé des Armées
Other
Acronym: COVIDAMBUCMA1
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05097677
COVID-19, COVID-19 Acute Bronchitis
Antwerp, Belgium
View Trial DetailsNCT04896866
COVID-19, COVID-19 Acute Respiratory Distress Syndrome
Edmonton, Alberta, Canada
View Trial DetailsNCT05073718
COVID-19, Coronaviridae Infections
Maputo, Mozambique
View Trial DetailsNCT04887246
COVID-19, Coronaviridae Infections
Bogotá, Colombia
View Trial Details